So the aim of this work was to assess risk habits, clinical and cellular phenotypes and TP53 DNA changes in oral mucosa samples from patients with OPMD, in order to create models that enable genotypic and phenotypic patterns to be obtained that determine the risk of lesions becoming malignant. Here, TP53 is linked to oculopharyngeal muscular dystrophy.